Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Theravance Biopharma, Inc. (TBPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/10/2023 |
SC 13G/A
| Baupost Group reports a 12.8% stake in Theravance Biopharma, Inc. |
| 02/14/2023 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 0% stake in Theravance Biopharma, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.2% stake in Theravance Biopharma Inc. |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.3% stake in Theravance Biopharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Madison Avenue Partners, LP reports a 9% stake in Theravance Biopharma, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.6% stake in Theravance Biopharma Inc. |
| 02/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/12/2021 |
SC 13G/A
| FMR LLC reports a 3.6% stake in THERAVANCE BIOPHARMA INC |
| 10/08/2021 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 0.3% stake in Theravance Biopharma, Inc. |
| 04/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/23/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/09/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 15% stake in THERAVANCE BIOPHARMA INC |
| 02/06/2020 |
SC 13G/A
| BlackRock Inc. reports a 6.7% stake in THERAVANCE BIOPHARMA INC |
| 11/08/2019 |
SC 13G/A
| Woodford Investment Management LLP reports a 0.8% stake in Theravance Biopharma, Inc. |
| 02/14/2019 |
SC 13G/A
| Woodford Investment Management LLP reports a 22.2% stake in Theravance Biopharma, Inc. |
| 02/14/2019 |
SC 13G/A
| CF Woodford Equity Income Fund reports a 19.1% stake in Theravance Biopharma, Inc. |
| 02/13/2019 |
SC 13G/A
| FMR LLC reports a 15% stake in THERAVANCE BIOPHARMA INC |
| 02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|